Sihuan Pharma launched Equity Incentive Plan to inject new impetus

Hong Kong-based Sihuan Pharmaceutical Holdings Group Ltd. announced that on 26 August 2020, the Company granted a t...

August 27, 2020 | Thursday | News
Graft versus host disease market to grow at 8.2% CAGR across 5 APAC markets in 10 years

The market for graft versus host disease (GvHD) prophylaxis and treatment in the five growth markets (5GM*) in the Asia-...

August 27, 2020 | Thursday | News
HKBN unveils UV-C disinfection to fight COVID-19

HKBN Enterprise Solutions has announced the launch of innovative, one-stop disinfection solutions to help companies main...

August 27, 2020 | Thursday | News
Sinovac inks new agreements for COVID-19 vaccine cooperation

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, has announced it has signed two agreeme...

August 26, 2020 | Wednesday | News
The 4th Shizhu health and wellness conference opens in China

The 4th China Chongqing (Shizhu) health and wellness conference opened on Aug 22 in Huangshui Town, Shizhu County. At th...

August 25, 2020 | Tuesday | News
Thermo Fisher inks CDx agreement with Hengrui Therapeutics

Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a US s...

August 24, 2020 | Monday | News
Ascletis completes bridging study of ASC18

China-based Ascletis Pharma Inc. recently announced that it completed bridging study of ASC18, the first one-pill, ...

August 21, 2020 | Friday | News
Mindray sets new standard for infusion systems

China based Mindray, a leading provider of medical devices and solutions, has released its new generation infusion syste...

August 20, 2020 | Thursday | News
Hua Medicine, Bayer bring novel diabetes treatment in China

Bayer and Hua Medicine, a leading innovative drug development company, have announced a commercialization agreement and ...

August 19, 2020 | Wednesday | News
NMPA approves China's first trastuzumab biosimilar

  Shanghai-based Henlius Biotech, Inc. (HK) recently announced that the trastuzumab biosimilar HLX02, develop...

August 18, 2020 | Tuesday | News
HiFiBiO collaborates with coronavirus immunotherapy consortium

HiFiBiO Therapeutics, a multinational biotherapeutics company focused on the development of novel antibodies for immunom...

August 18, 2020 | Tuesday | News
Ascletis Pharma announces first dosing of HBV patient in ASC22 trial

China-based Ascletis Pharma Inc. recently announced the dosing of the first HBV patient in Phase IIa clinical trial of A...

August 17, 2020 | Monday | News
CUHK study suggests Hot Nights pose greater threat to public health than Hot Days

Hong Kong has been experiencing hotter summers and more scorcher days in recent years due to climate change and heat isl...

August 17, 2020 | Monday | News
CanSinoBIO lists successfully on STAR Market as Initial dual listing vaccine company

China's CanSino Biologics Inc. announced on 13 August 2020 that it has successfully listed on the Sci-Tech Innovati...

August 14, 2020 | Friday | News
Viva Biotech acquires major stake in Chinese CDMO

Viva Biotech (Shanghai) Co., Ltd. has entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to...

August 14, 2020 | Friday | News
Antengene announces approval of first Ph I Trial of ATG-017

Shanghai-based Antengene Corporation, leading innovative hematology and oncology-focused biopharmaceutical company, anno...

August 13, 2020 | Thursday | News
SCMP’s China Healthcare Report reveals World’s Second-Largest Healthcare Market

South China Morning Post announced on 13 August 2020 the release of its inaugural China Healthcare Report that...

August 13, 2020 | Thursday | News
Innovent & Lilly announce acceptance of new drug application for TYVYT® (sintilimab injection)

China-based Innovent Biologics, Inc. (Innovent), jointly announced with Eli Lilly and Company (Lilly) that the National ...

August 12, 2020 | Wednesday | News